2012 Cattlemen's Ball tickets officially sold out
4,000 tickets sold represent earliest sellout ever for annual cancer research fundraiser
McCool Junction, NE - The 2012 Cattlemen's Ball is officially sold out.
All 4,000 tickets have been sold. This includes both the Top Hand and Trail Boss levels. The annual event will be held this year in McCool Junction on June 1-2 to raise money for cancer research.
Dana Matzner with Cornerstone Bank in McCool Junction said, “We sold out of all tickets March 1 - that's the quickest sellout ever! Trail Boss tickets actually sold out Feb. 23.”
While tickets are no longer available, there are still a number of ways to help the Cattlemen's Ball reach its fundraising goal. These include sponsoring a Promise Petal centerpiece in memory of a loved one, donating an auction item or volunteering your time.
For a complete list of volunteer and donation opportunities, including how to make an online contribution, visit www.cattlemensball.com.
The Cattlemen’s Ball is hosted by a different Nebraska ranch or feedlot every year. This year’s event is hosted by Allen and Shelly Clark. Its mission is to raise money for cancer research at the Eppley Cancer Center at the University of Nebraska Medical Center, while showcasing rural Nebraska and promoting beef as part of a healthy diet.
Since its inception, the Cattlemen’s Ball has raised more than $6.29 million. In addition to providing funds to the UNMC Eppley Cancer Center, a portion of the funds also is given to local health care organizations.
Through world-class research and patient care, UNMC generates breakthroughs that make life better for people throughout Nebraska and beyond. Learn more at www.unmc.edu.
The UNMC Eppley Cancer Center is a National Cancer Institute (NCI)-designated cancer center -- a distinction held by only 66 centers in the country and the only NCI-designated center in Nebraska. The UNMC Eppley Cancer Center also is one of the founding members of the National Comprehensive Cancer Network, an alliance of the world's leading cancer centers. This recognition means the most current and innovative treatment options are available to cancer center patients through the integration of cutting-edge research into state-of-the-art care. Cancer center physicians and scientists work together to quickly translate discoveries made in the laboratory into innovative treatments for the patient.